148 related articles for article (PubMed ID: 12359310)
1. Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla.
Narita M; Mizoguchi H; Khotib J; Suzuki M; Ozaki S; Yajima Y; Narita M; Tseng LF; Suzuki T
Neurosci Lett; 2002 Oct; 331(1):5-8. PubMed ID: 12359310
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
3. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF
Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410
[TBL] [Abstract][Full Text] [Related]
5. The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice.
Mizoguchi H; Narita M; Oji DE; Suganuma C; Nagase H; Sora I; Uhl GR; Cheng EY; Tseng LF
Neuroscience; 1999; 94(1):203-7. PubMed ID: 10613510
[TBL] [Abstract][Full Text] [Related]
6. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
[TBL] [Abstract][Full Text] [Related]
7. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
[TBL] [Abstract][Full Text] [Related]
8. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
[TBL] [Abstract][Full Text] [Related]
9. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
[TBL] [Abstract][Full Text] [Related]
10. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.
Ozaki S; Narita M; Narita M; Iino M; Miyoshi K; Suzuki T
Neuroscience; 2003; 116(1):89-97. PubMed ID: 12535942
[TBL] [Abstract][Full Text] [Related]
12. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
13. Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors.
Mizoguchi H; Narita M; Nagase H; Tseng LF
Life Sci; 2000 Oct; 67(22):2733-43. PubMed ID: 11105989
[TBL] [Abstract][Full Text] [Related]
14. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
Albrecht E; Samovilova NN; Oswald S; Baeger I; Berger H
J Pharmacol Exp Ther; 1998 Aug; 286(2):896-902. PubMed ID: 9694948
[TBL] [Abstract][Full Text] [Related]
16. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
18. [(35)S]GTPĪ³S binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
19. Decreased opioid-induced antinociception but unaltered G-protein activation in the genetic-diabetic NOD mouse.
Pieper GM; Mizoguchi H; Ohsawa M; Kamei J; Nagase H; Tseng LF
Eur J Pharmacol; 2000 Aug; 401(3):375-9. PubMed ID: 10936496
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment.
Narita M; Suzuki M; Mizoguchi H; Narita M; Yajima Y; Sakurada S; Tseng LF; Suzuki T
Neurosci Lett; 2003 Feb; 338(2):103-6. PubMed ID: 12566163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]